Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_assertion type Assertion NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_head.
- NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_assertion wasGeneratedBy ECO_0000203 NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_provenance.
- NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_assertion wasDerivedFrom befree-20150227 NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_provenance.
- NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_assertion SIO_000772 17949785 NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_provenance.
- NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_assertion evidence source_evidence_literature NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_provenance.
- NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_assertion description "[We conclude that the immunohistochemical loss of FHIT expression and the positivity for beta-catenin and MUC1 in NSCLC are useful prognostic markers, whereas the variable expression of TP53, TOP2A, and FGFR3 in relation to the different histologic types of NSCLC and sex of the patients is suggestive for different underlying molecular pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400859.RAx3DcOlUkMaXN2BG9-6L1XJSoF8ZJo1nNw-J6OCReGcc130_provenance.